Relationship between serum leptin level and disease activity in patients with systemic sclerosis

Clinical Rheumatology

Volumn 33, Issue 3, 2014, Pages 335-339

  Budulgan, Mahmut ^a   Dilek, Banu ^a   Daǧ, Şevin Buluttekin ^a   Batmaz, Ibrahim ^a   Yildiz, Ismail ^a   Sariyildiz, Mustafa Akif ^a   Çevik, Remzi ^a   Nas, Kemal ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

BMI; Disease activity; Leptin; Systemic sclerosis

Indexed keywords

C REACTIVE PROTEIN; LEPTIN;

ADULT; ARTHRITIS; ARTICLE; ATROPHY; BODY MASS; CALCINOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DYSPEPSIA; DYSPHAGIA; DYSPNEA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLEXION CONTRACTURE; GOUT; HUMAN; LEPTIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCLERODERMA DISEASE ACTIVITY INDEX; SCLEROSIS; SYSTEMIC SCLEROSIS; TELANGIECTASIA; WEIGHT REDUCTION;

ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; FEMALE; HUMANS; INFLAMMATION; LEPTIN; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 84896494072     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2459-0     Document Type: Article

References (30)

1. Gilliland BC (2001) Systemic sclerosis (scleroderma). In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds) Harrison's principles of internal medicine, 15th edn. McGraw-Hil, New York, pp 1937-1945
2. Valentini G, Della Rossa A, Bombardieri S (2001) European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indices. Ann Rheum 60:592-598 (Pubitemid 32493986)
3. Clements P, Lachenbruch P, Seibold J, Wigley FM (1995) Inter- and intraobserver variability of total skin thickness score (modified Rodnan) in systemic sclerosis (SSc). J Rheum 22:1281-1285
4. Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA et al (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheum 26:2159-2167 (Pubitemid 29487010)
5. Mantzoros CS, Flier JS (2000) Editorial: leptin as a therapeutic agent - trials and tribulations. J Clin Endocrinol Metab 85(11):4000-4002 (Pubitemid 32055342)
6. Aslan K, Serdar Z, Tokullugil AH (2004) Multifonksiyonel hormon: leptin. Uludag Üniversitesi tip fakültesi Dergisi 30:113-118
7. Prions KB, O'Rahilly S (1997) Regulation of adipose cell number in man. Clin Sci 92:311
8. Satoh N, Ogawa Y, Katsuura G et al (1997) Pathophysiological significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)-lesioned rats: evidence for loss of its satiety effect in VMH-lesioned rats. Endocrinology 138(3):947-954 (Pubitemid 27089745)
9. Clement K (1999) Leptin and the genetics of obesity. Acta Pediatr Suppl 88:51-57
10. Fantuzzi G, Faggioni R (2000) Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 68:437-446
11. Anders HJ, Rihl M, Heufelder A, Loch O, Schattenkirchner M (1999) Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis. Metabolism 48(6):745-748 (Pubitemid 29277646)
12. Popa C, Netea MG, Radstake TR, Van der Meer JW, Stalenhoef AF, van Riel PL et al (2005) Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis 64(8):1195-1198 (Pubitemid 41113356)
13. Gunaydin R, Kaya T, Atay A, Olmez N, Hur A, Koseoglu M (2006) Serum leptin levelsvin rheumatoid arthritis and relationship with disease activity. South Med J 99(10):1078-1083 (Pubitemid 44631238)
14. Bokarewa M, Bokarew D, Hultgren O, Tarkowski A (2003) Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis 62(10):952-956 (Pubitemid 37159493)
15. Toussirot E, Streit G, Nguyen NU, Dumoulin G, Le Huédé G, Saas P et al (2007) Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis. Metabolism 56(10):1383-1389 (Pubitemid 47404601)
16. Sari I, Demir T, Kozaci LD, Akar S, Kavak T, Birlik M et al (2007) Body composition, insulin, and leptin levels in patients with ankylosing spondylitis. Clin Rheumatol 26(9):1427-1432 (Pubitemid 47193559)
17. Park MC, Lee SW, Choi ST, Park YB, Lee SK (2007) Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis. Scand J Rheumatol 36(2):101-106
18. Kavuncu S, Koç F, Kurt M, Eryüksel B, Ortaç S, Ozdal P, Firat E (2005) Evaluation of serum leptin concentration in Behçet's disease with ocular involvement. Graefes Arch Clin Exp Ophthalmol 243(11):1158-1160 (Pubitemid 43124168)
19. Evereklioglu C, Inalöz HS, Kirtak N, Doganay S, Bülbül M, Ozerol E, Er H, Ozbek E (2002) Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity. Br J Dermatol 147(2):331-336
20. Wisłowska M, Rok M, Stepień K, Kuklo-Kowalska A (2008) Serum leptin in systemic lupus erythematosus. Rheumatol Int 28(5):467-473
21. Kotulska A, Kucharz EJ, Brzezińska-Wcisło L, Wadas U (2001) A decreased serum leptin level in patients with systemic sclerosis. Clin Rheumatol 20(4):300-302 (Pubitemid 32776482)
22. Riccieri V, Stefanantoni K, Vasile M, Macrì V, Sciarra I, Iannace N, Alessandri C, Valesini G (2011) Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis. Clin Exp Rheumatol 29(2 Suppl 65):S46-S52
23. Pehlivan Y, Onat AM, Ceylan N, Turkbeyler IH, Buyukhatipoglu H, Comez G, Babacan T, Tarakcioglu M (2012) Serum leptin, resistin and TNF-α levels in patients with systemic sclerosis: the role of adipokines in scleroderma. Int J Rheum Dis 15(4):374-379
24. Masi AT, Rodnan GP, Medsger TA Jr et al (1980) Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590
25. Clements P, Lachenbruch P, Siebold J et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22(7):1281-1285
26. Valentini G, D'Angelo S, Della Rossa A, Bencivelli W, Bombardieri S (2003) European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score. Ann Rheum Dis 62(9):904-905 (Pubitemid 37026506)
27. La Cava A, Matarese G (2004) The weight of leptin in immunity. Nat Rev Immunol 4:371-379 (Pubitemid 38649279)
28. La Cava A, Alviggi C, Matarese G (2004) Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med 82:4-11 (Pubitemid 38168097)
29. Shamsuzzaman AS, Winnicki M, Wolk R et al (2004) Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 109:2181-2185 (Pubitemid 38625394)
30. Dagogo JS, Fanelli C, Paramore D et al (1996) Plasma leptin and insulin relationships in obese and nonobese humans (abstract). Diabetes 45:695-698 (Pubitemid 26142811)